Risa Stack of The Production Board joins Nate to discuss Can BioTech Extend Life to 150 Years? Gene Editing, and Investing in the Future of Life Sciences. In this episode we cover:

Entrepreneurship, Venture Capital, and Starting Companies
Venture Studio Model, Technical Risk, and Investing in Businesses
Challenges in Therapeutic Development and Commercialization
Prioritizing People Over Products, and Assessing the Funding Environment for Critical Industries
Biotech, Life Extension, and Investment Strategies
Gene Editing and Cell Therapy Technologies
Personalized Medicine

Guest Links:

The hosts of The Full Ratchet are Nick Moran and Nate Pierotti of New Stack Ventures, a venture capital firm committed to investing in founders outside of the Bay Area.

Want to keep up to date with The Full Ratchet? Follow us on social.

You can learn more about New Stack Ventures by visiting our LinkedIn and Twitter.

Are you a founder looking for your next investor? Visit our free tool VC-Rank and we’ll send a list of potential investors right to your inbox!

403. Can BioTech Extend Life to 150 Years? Gene Editing, and Investing in the Future of Life Sciences (Risa Stack)

The Full Ratchet (TFR): Venture Capital and Startup Investing Demystified

403. Can BioTech Extend Life to 150 Years? Gene Editing, and Investing in the Future of Life Sciences (Risa Stack)